$SIGA
SIGA TECHNOLOGIES INC Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000101008614000026 Filed on November 04, 2014

Income Statement

Concept	2014 Q4	2014 Q3	2013 Q3
Revenue	$800.0K	$1.100M	$2.300M
YoY Change	-11.11%	-52.17%	0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.423M	$4.314M	$3.215M
YoY Change	-35.06%	34.18%	2.42%
% of Gross Profit
Research & Development	$2.903M	$2.742M	$4.261M
YoY Change	2.98%	-35.65%	2.18%
% of Gross Profit
Depreciation & Amortization	$80.00K	$87.23K	$116.6K
YoY Change	-42.86%	-25.2%	16.62%
% of Gross Profit
Operating Expenses	$5.326M	$182.8M	$7.856M
YoY Change	-18.69%	2227.31%	2.21%
Operating Profit	-$17.55M	-$181.7M	-$5.564M
YoY Change	169.52%	3166.14%	3.11%
Interest Expense	-$100.0K	$105.1K	$293.4K
YoY Change	-120.0%	-64.17%
% of Operating Profit
Other Income/Expense, Net	$0.00	$5.00	$5.00
YoY Change		0.0%	-94.68%
Pretax Income	-$19.50M	-$182.1M	-$6.592M
YoY Change	225.0%	2662.8%	19.22%
Income Tax	-$400.0K	$57.95M	-$1.690M
% Of Pretax Income
Net Earnings	-$19.06M	-$240.1M	-$4.902M
YoY Change	339.28%	4797.53%	60.25%
Net Earnings / Revenue	-2382.0%	-21825.18%	-213.13%
Basic Earnings Per Share
Diluted Earnings Per Share	-$357.0K	-$4.488M	-$93.33K
COMMON SHARES
Basic Shares Outstanding	53.50M shares	53.50M shares	52.48M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q4	2014 Q3	2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$99.70M	$104.7M	$105.2M
YoY Change	9.2%	-0.48%	363.44%
Cash & Equivalents	$99.71M	$104.7M	$105.2M
Short-Term Investments
Other Short-Term Assets	$10.60M	$700.0K	$20.50M
YoY Change	-5.36%	-96.59%	1364.29%
Inventory	$19.04M	$18.13M	$16.99M
Prepaid Expenses
Receivables	$491.6K	$569.1K	$741.9K
Other Receivables	$0.00	$0.00	$500.0K
Total Short-Term Assets	$124.1M	$124.1M	$143.9M
YoY Change	0.17%	-13.73%	238.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$831.9K	$913.3K	$1.236M
YoY Change	-39.81%	-26.13%	59.59%
Goodwill	$898.3K	$898.3K	$898.3K
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.990M	$1.992M	$2.137M
YoY Change	-4.27%	-6.83%	31.47%
Total Long-Term Assets	$36.58M	$40.61M	$57.72M
YoY Change	-47.65%	-29.63%	16.57%
TOTAL ASSETS
Total Short-Term Assets	$124.1M	$124.1M	$143.9M
Total Long-Term Assets	$36.58M	$40.61M	$57.72M
Total Assets	$160.7M	$164.7M	$201.6M
YoY Change	-17.07%	-18.28%	118.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.384M	$680.9K	$6.827M
YoY Change	-33.17%	-90.03%	-35.68%
Accrued Expenses	$2.086M	$1.926M	$7.232M
YoY Change	-56.92%	-73.37%	39.52%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.990M	$1.985M	$1.964M
YoY Change	1.07%	1.06%
Total Short-Term Liabilities	$7.460M	$4.591M	$17.25M
YoY Change	-38.8%	-73.38%	9.2%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$499.5K	$2.484M
YoY Change	-100.0%	-79.89%
Other Long-Term Liabilities	$399.5M	$387.4M	$162.5M
YoY Change	145.54%	138.4%	265.17%
Total Long-Term Liabilities	$0.00	$499.5K	$2.484M
YoY Change	-100.0%	-79.89%	-94.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.460M	$4.591M	$17.25M
Total Long-Term Liabilities	$0.00	$499.5K	$2.484M
Total Liabilities	$407.2M	$392.7M	$182.2M
YoY Change	130.27%	115.47%	202.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$422.0M	-$402.9M	-$152.2M
YoY Change	169.59%	164.76%	26.6%
Common Stock	$175.5M	$175.0M	$171.5M
YoY Change	1.14%	2.01%	12.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$246.5M	-$228.0M	$19.32M
YoY Change
Total Liabilities & Shareholders Equity	$160.7M	$164.7M	$201.6M
YoY Change	-17.07%	-18.28%	118.97%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2013 Q3
OPERATING ACTIVITIES
Net Income	-$19.06M	-$240.1M	-$4.902M
YoY Change	339.28%	4797.53%	60.25%
Depreciation, Depletion And Amortization	$80.00K	$87.23K	$116.6K
YoY Change	-42.86%	-25.2%	16.62%
Cash From Operating Activities	-$4.460M	$10.12M	$79.68M
YoY Change	-68.92%	-87.3%	-750.45%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	-$210.0K
YoY Change	-100.0%	-100.0%	2000.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$3.960M	$0.00
YoY Change
Cash From Investing Activities	$0.00	-$3.970M	-$210.0K
YoY Change	-100.0%	1790.48%	950.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-500.0K	-500.0K	-7.250M
YoY Change	-165.79%	-93.1%	-72600.0%
NET CHANGE
Cash From Operating Activities	-4.460M	10.12M	79.68M
Cash From Investing Activities	0.000	-3.970M	-210.0K
Cash From Financing Activities	-500.0K	-500.0K	-7.250M
Net Change In Cash	-4.960M	5.650M	72.22M
YoY Change	-64.27%	-92.18%	-689.07%
FREE CASH FLOW
Cash From Operating Activities	-$4.460M	$10.12M	$79.68M
Capital Expenditures	$0.00	$0.00	-$210.0K
Free Cash Flow	-$4.460M	$10.12M	$79.89M
YoY Change	-68.28%	-87.33%	-752.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5064380	USD
CY2014Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	680930	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	982023	USD
CY2014Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	569061	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4842393	USD
CY2014Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1925696	USD
CY2013Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	794275	USD
CY2014Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	544537	USD
CY2013Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	252410	USD
CY2014Q3	us-gaap	Accrued Vacation Current AccruedVacationCurrent	256956	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5401509	USD
CY2014Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3413726	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	173498028	USD
CY2014Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	174952893	USD
CY2014Q3	us-gaap	Assets Assets	164715384	USD
CY2013Q4	us-gaap	Assets Assets	193824234	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	124102788	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	123941842	USD
CY2014Q3	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	110000000	shares
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	104682642	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	91309754	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	105190655	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32017490	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	73173165	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	13372888	USD
CY2014Q3	us-gaap	Cash Collateral For Borrowed Securities CashCollateralForBorrowedSecurities	4000000	USD
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53108844	shares
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53504296	shares
CY2014Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53504296	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53108844	shares
CY2014Q3	us-gaap	Common Stock Value CommonStockValue	5351	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	5310	USD
	us-gaap	Debtor Reorganization Items Legal And Advisory Professional Fees DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees	223422	USD
	us-gaap	Debtor Reorganization Items Other Expense Income DebtorReorganizationItemsOtherExpenseIncome	70000	USD
CY2014Q3	us-gaap	Deferred Costs DeferredCosts	32809441	USD
CY2013Q4	us-gaap	Deferred Costs DeferredCosts	22583202	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	53565505	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7252373	USD
CY2013Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	162222189	USD
CY2014Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	10383908	USD
CY2014Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	42940624	USD
CY2014Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	0	USD
CY2014Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	54000000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	0	USD
	us-gaap	Liabilities Subject To Compromise Period Increase Decrease LiabilitiesSubjectToCompromisePeriodIncreaseDecrease	0	USD
CY2014Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	240973	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	319377	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	268037	USD
CY2013Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	116618	USD
CY2014Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	87233	USD
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.49
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.62
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.25
CY2013Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	488168	USD
CY2014Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	486656	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	321887	USD
CY2014Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	23771	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	345658	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2013Q4	us-gaap	Goodwill Goodwill	898334	USD
CY2014Q3	us-gaap	Goodwill Goodwill	898334	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18773682	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-182123716	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-192470150	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6592004	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1690028	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	57953045	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	53936733	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5934806	USD
CY2013Q3	us-gaap	Interest Expense InterestExpense	293438	USD
	us-gaap	Interest Expense InterestExpense	1043316	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	105149	USD
	us-gaap	Interest Expense InterestExpense	369587	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12189024	USD
CY2014Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4591176	USD
CY2014Q3	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	386944313	USD
CY2013Q4	us-gaap	Liabilities Subject To Compromise LiabilitiesSubjectToCompromise	0	USD
	us-gaap	Liabilities Subject To Compromise Period Increase Decrease LiabilitiesSubjectToCompromisePeriodIncreaseDecrease	386944313	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-7120486	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-127579	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3548404	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-412962	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	19046118	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	10226239	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-162222189	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	105005510	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-653903	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2388438	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-122438	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-18465	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	122200	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-29306	USD
CY2014Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	0	USD
CY2013Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	6152198	USD
CY2014Q3	us-gaap	Inventory Net InventoryNet	18126911	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	20515349	USD
CY2013Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	14363151	USD
CY2014Q3	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	18126911	USD
CY2014Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3170597	USD
CY2013Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	3166622	USD
CY2013Q4	us-gaap	Liabilities Liabilities	176848766	USD
CY2014Q3	us-gaap	Liabilities Liabilities	392691893	USD
CY2014Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	164715384	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	193824234	USD
CY2014Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	499536	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1989948	USD
CY2014Q3	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	174934726	USD
CY2014Q3	us-gaap	Long Term Debt LongTermDebt	2500000	USD
CY2014Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	1984550	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1968826	USD
CY2014Q3	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	173000000	USD
CY2014Q3	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	0	USD
CY2013Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	2635270	USD
	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	233000000	USD
	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	175565839	USD
CY2013Q3	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	50538	USD
	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	146668	USD
CY2014Q3	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	175465718	USD
CY2013Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	2473428	USD
CY2014Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	952797	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1813904	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3456287	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-567881	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	72788249	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	18643079	USD
	us-gaap	Net Income Loss NetIncomeLoss	-246406883	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	-240076761	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12838876	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-4901976	USD
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1061	USD
CY2014Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1489	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	182827596	USD
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	7855759	USD
	us-gaap	Operating Expenses OperatingExpenses	194412568	USD
	us-gaap	Operating Expenses OperatingExpenses	21588164	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-192113112	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-17002990	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-181728167	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5563616	USD
CY2013Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3215197	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	37824	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	25312	USD
CY2014Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1124203	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1160438	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2078159	USD
CY2014Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1991512	USD
CY2014Q3	us-gaap	Other Liabilities OtherLiabilities	415895	USD
CY2013Q4	us-gaap	Other Liabilities OtherLiabilities	447605	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	211372	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	4000000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	114180	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	178093	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	415938	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	567881	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	25894	USD
CY2014Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2014Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	724174	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	750808	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	7000000	USD
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	USD
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	569607	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	534607	USD
CY2014Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	35000	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2742329	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4260970	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2014Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4000000	USD
CY2014Q2	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	212720	USD
CY2014Q3	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	11228	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6783582	USD
CY2014Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4327035	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1382073	USD
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	913309	USD
	siga	Potentialmilestonepayments Potentialmilestonepayments	5000000	USD
	us-gaap	Reorganization Items ReorganizationItems	0	USD
CY2013Q3	us-gaap	Reorganization Items ReorganizationItems	0	USD
CY2014Q3	us-gaap	Reorganization Items ReorganizationItems	301937	USD
	us-gaap	Reorganization Items ReorganizationItems	301937	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1500001	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7500000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11037140	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7927655	USD
CY2013	us-gaap	Restructuring Charges RestructuringCharges	512944	USD
CY2014Q3	us-gaap	Restructuring Reserve RestructuringReserve	4050	USD
CY2013Q4	us-gaap	Restructuring Reserve RestructuringReserve	118230	USD
CY2014Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-402934753	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-156527870	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10101130	USD
CY2014Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4313540	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9316565	USD
	us-gaap	Severance Costs1 SeveranceCosts1	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1836993	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1759074	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	16975468	USD
CY2014Q3	us-gaap	Stockholders Equity StockholdersEquity	-227976509	USD
CY2013Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	52548997	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	52162380	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	53391173	shares
CY2014Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	53504296	shares
CY2013Q3	siga	Change In Fair Value Of Common Stock Warrants ChangeInFairValueOfCommonStockWarrants	734955	USD
	siga	Change In Fair Value Of Common Stock Warrants ChangeInFairValueOfCommonStockWarrants	-313425	USD
CY2014Q3	siga	Change In Fair Value Of Common Stock Warrants ChangeInFairValueOfCommonStockWarrants	-11532	USD
	siga	Change In Fair Value Of Common Stock Warrants ChangeInFairValueOfCommonStockWarrants	728865	USD
CY2014Q3	siga	Changein Fair Valueof Common Stock Warrants2008 ChangeinFairValueofCommonStockWarrants2008	80924	USD
CY2014Q3	siga	Collateral Collateral	0.50
CY2014Q3	siga	Common Stock Warrants Current Fair Value Disclosure CommonStockWarrantsCurrentFairValueDisclosure	0	USD
CY2013Q4	siga	Common Stock Warrants Current Fair Value Disclosure CommonStockWarrantsCurrentFairValueDisclosure	313425	USD
CY2014Q3	siga	Computer Equipment ComputerEquipment	669782	USD
CY2013Q4	siga	Computer Equipment ComputerEquipment	655364	USD
CY2014Q3	siga	Expenseof Warrants Heldas Assets ExpenseofWarrantsHeldasAssets	34091	USD
CY2013Q3	siga	Expenseof Warrants Heldas Assets ExpenseofWarrantsHeldasAssets	34091	USD
	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	728865	USD
	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	-313425	USD
	siga	Inventory Write Downs InventoryWriteDowns	900000	USD
CY2014Q3	siga	Inventory Write Downs InventoryWriteDowns	0	USD
	siga	Potentialroyalties Potentialroyalties	0.04
CY2014Q3	siga	Liabilitiessubjecttocompromiseaccountspayable Liabilitiessubjecttocompromiseaccountspayable	3816684	USD
CY2014Q3	siga	Liabilitiessubjecttocompromisedeferredrevenue Liabilitiessubjecttocompromisedeferredrevenue	203526317	USD
CY2014Q3	siga	Liabilitiessubjecttocompromiselosscontingencylegalfees Liabilitiessubjecttocompromiselosscontingencylegalfees	3226055	USD
CY2014Q3	siga	Liabilitiessubjecttocompromiseotheraccruedexpense Liabilitiessubjecttocompromiseotheraccruedexpense	1440531	USD
	siga	Number Of Active Contracts NumberOfActiveContracts	1	contract
	siga	Number Of Active Grants NumberOfActiveGrants	1	grant
	siga	Patent Preparation Fees PatentPreparationFees	1087791	USD
CY2014Q3	siga	Patent Preparation Fees PatentPreparationFees	306009	USD
	siga	Patent Preparation Fees PatentPreparationFees	817944	USD
CY2013Q3	siga	Patent Preparation Fees PatentPreparationFees	329054	USD
CY2014Q3	siga	Payment To Post Collateral For Surety Bond PaymentToPostCollateralForSuretyBond	1300000	USD
CY2014Q3	siga	Potential Future Aggregate Research And Development Expenses PotentialFutureAggregateResearchAndDevelopmentExpenses	9500000	USD
	siga	Proceeds From Issuance Of Warrants And Options ProceedsFromIssuanceOfWarrantsAndOptions	1630890	USD
	siga	Proceeds From Issuance Of Warrants And Options ProceedsFromIssuanceOfWarrantsAndOptions	102035	USD
	siga	Reclass Of Common Stock Warrant Liability To Additional Paid In Capital Upon Exercise ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise	492191	USD
	siga	Reclass Of Common Stock Warrant Liability To Additional Paid In Capital Upon Exercise ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise	0	USD
CY2014Q3	siga	Reimbursableprepetitionaccountspayable Reimbursableprepetitionaccountspayable	557000	USD
CY2014Q3	siga	Reimbursableprepetitionotheraccruedexpenses Reimbursableprepetitionotheraccruedexpenses	121000	USD
	siga	Reorganization Professional Fees ReorganizationProfessionalFees	6890	USD
	siga	Reorganization Trusteefees ReorganizationTrusteefees	1625	USD
CY2014Q3	siga	Reorganizationitemscashpaid Reorganizationitemscashpaid	90565	USD
CY2014Q3	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	1099429	USD
	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	4585174	USD
	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	2299456	USD
CY2013Q3	siga	Research And Development Revenue ResearchAndDevelopmentRevenue	2292143	USD
CY2014Q3	siga	Researchand Development Revenue Longterm Contract ResearchandDevelopmentRevenueLongtermContract	1060576	USD
	siga	Researchand Development Revenue Longterm Contract ResearchandDevelopmentRevenueLongtermContract	1677626	USD
	siga	Restructuringand Related Cost Expected Expense Reduction RestructuringandRelatedCostExpectedExpenseReduction	6000000	USD
CY2014Q3	siga	Suretybond Suretybond	2700000	USD
CY2014Q3	siga	Terminationofrevolvingloan Terminationofrevolvingloan	70000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Period End Date DocumentPeriodEndDate	2014-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001010086
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	53504296	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	SIGA TECHNOLOGIES INC
	dei	Trading Symbol TradingSymbol	SIGA

Files In Submission

Name	View Source	Status
0001010086-14-000026-index-headers.html	Edgar Link	pending
0001010086-14-000026-index.html	Edgar Link	pending
0001010086-14-000026.txt	Edgar Link	pending
0001010086-14-000026-xbrl.zip	Edgar Link	pending
a8thaddendum.jpg	Edgar Link	pending
a8thaddenduma1.jpg	Edgar Link	pending
corvallismainentrancea01.jpg	Edgar Link	pending
exhbiticorvallisfirstfloor.jpg	Edgar Link	pending
exhibit101-commerciamanufa.htm	Edgar Link	pending
exhibit102-addendum1tocomm.htm	Edgar Link	pending
exhibit103-addendum2tocomm.htm	Edgar Link	pending
exhibit104-addendum3tocomm.htm	Edgar Link	pending
exhibit106-2013x01x09comme.htm	Edgar Link	pending
exhibit107-commerciallease.htm	Edgar Link	pending
exhibitadownstairsfloorplan.jpg	Edgar Link	pending
exhibitaexpansionarea.jpg	Edgar Link	pending
exhibitafloorplan.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-20140930.xml	Edgar Link	completed
siga-20140930.xsd	Edgar Link	pending
siga-20140930_cal.xml	Edgar Link	unprocessable
siga-20140930_def.xml	Edgar Link	unprocessable
siga-20140930_lab.xml	Edgar Link	unprocessable
siga-20140930_pre.xml	Edgar Link	unprocessable
siga-2014930x10q.htm	Edgar Link	pending
siga-exhibit3112014q3.htm	Edgar Link	pending
siga-exhibit3122014q3.htm	Edgar Link	pending
siga-exhibit3212014q3.htm	Edgar Link	pending
siga-exhibit3222014q3.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA TECHNOLOGIES INC Stock $siga

2014 Q4 Form 10-Q Financial Statement

#000101008614000026 Filed on November 04, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA TECHNOLOGIES INC Stock $siga

2014 Q4 Form 10-Q Financial Statement

#000101008614000026 Filed on November 04, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA TECHNOLOGIES INC Stock $siga